Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / SILO - Psyched: MDMA Trials For PTSD Congressional Amendments Scotland's Consumption Site & More | Benzinga


SILO - Psyched: MDMA Trials For PTSD Congressional Amendments Scotland's Consumption Site & More | Benzinga

Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next

MAPS Public Benefit Corporation (MAPS PBC), the nonprofit’s clinical-stage private arm, published new data from its second multi-site, ethno-racially diverse Phase 3 clinical study of MDMA-assisted therapy for PTSD in Nature Medicine. 

The randomized MAPP2 study gave participants a split dose, separated by 1.5 to 2 hours, of 80 or 120 mg of MDMA hydrochloride (or placebo,) and following a 40 to 60 mg dose during three therapy sessions. The placebo group received extended therapy sessions. Continue reading HERE.

Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips

Recent peer-reviewed research published in the journal Nature posits that a small dose of MDMA could be helpful against uncomfortable or difficult experiences and amplify positive ones when combined with either psilocybin or LSD.

The study, published in August and authored by researchers from Imperial College London (ICL) and New York University’s Langone Center for Psychedelic Medicine delves into a hypothesis of "candy-flipping,” clinical research conducted by MindMed’s (NASDAQ: MNMD) research collaborator Dr. Matthias Liechti and his team at University Hospital Basel. Read more HERE.

Congress Update: House Committee Green Lights Psychedelics Amendments

On September 12, the House Rules Committee voted on one of a series of large-scale budget bills which include recently introduced bipartisan marijuana and psychedelics amendments.

The committee’s decision is key, as it is the immediate prior step for proposals to make it, or not, to the House floor. The vote was around the Department of Defense (DoD) FY2024 appropriations bill HR 4365. Read more HERE.

Scotland's Approval Of Pilot 'Safer' Drug Consumption Site, Overdose Prevention Debate In UK

Scottish Advocate, the country's top attorney, replied to a request from the Parliament’s cross-committee on tackling ...

Full story available on Benzinga.com

Stock Information

Company Name: SILO Pharma Inc
Stock Symbol: SILO
Market: NASDAQ
Website: silopharma.com

Menu

SILO SILO Quote SILO Short SILO News SILO Articles SILO Message Board
Get SILO Alerts

News, Short Squeeze, Breakout and More Instantly...